nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlexanox—FGF1—periosteum—osteoporosis	0.0262	0.607	CbGeAlD
Amlexanox—Throat sore—Ibandronate—osteoporosis	0.0141	0.0502	CcSEcCtD
Amlexanox—Oropharyngeal discomfort—Ibandronate—osteoporosis	0.014	0.0497	CcSEcCtD
Amlexanox—Oropharyngeal pain—Ibandronate—osteoporosis	0.0112	0.0398	CcSEcCtD
Amlexanox—IL3—bone marrow—osteoporosis	0.0104	0.241	CbGeAlD
Amlexanox—Throat sore—Zoledronate—osteoporosis	0.0101	0.0359	CcSEcCtD
Amlexanox—Oropharyngeal discomfort—Zoledronate—osteoporosis	0.01	0.0356	CcSEcCtD
Amlexanox—Mouth ulceration—Ibandronate—osteoporosis	0.0092	0.0327	CcSEcCtD
Amlexanox—Oropharyngeal pain—Zoledronate—osteoporosis	0.00801	0.0285	CcSEcCtD
Amlexanox—S100A13—Estriol—Estropipate—osteoporosis	0.0066	0.328	CbGdCrCtD
Amlexanox—Paraesthesia—Calcium Acetate—osteoporosis	0.00599	0.0213	CcSEcCtD
Amlexanox—Pain—Calcium Acetate—osteoporosis	0.0057	0.0203	CcSEcCtD
Amlexanox—Stomatitis—Alendronate—osteoporosis	0.0057	0.0203	CcSEcCtD
Amlexanox—Liver function test abnormal—Risedronate—osteoporosis	0.00562	0.02	CcSEcCtD
Amlexanox—Stomatitis—Ibandronate—osteoporosis	0.00555	0.0197	CcSEcCtD
Amlexanox—Liver function test abnormal—Pamidronate—osteoporosis	0.00534	0.019	CcSEcCtD
Amlexanox—Pain—Ergocalciferol—osteoporosis	0.00504	0.0179	CcSEcCtD
Amlexanox—S100A13—Estriol—Conjugated Estrogens—osteoporosis	0.005	0.249	CbGdCrCtD
Amlexanox—S100A12—bone marrow—osteoporosis	0.00488	0.113	CbGeAlD
Amlexanox—Stomatitis—Pamidronate—osteoporosis	0.00435	0.0155	CcSEcCtD
Amlexanox—S100A13—Estriol—Estradiol—osteoporosis	0.00431	0.214	CbGdCrCtD
Amlexanox—S100A13—Estriol—Ethinyl Estradiol—osteoporosis	0.0042	0.209	CbGdCrCtD
Amlexanox—Stomatitis—Zoledronate—osteoporosis	0.00397	0.0141	CcSEcCtD
Amlexanox—Nausea—Calcium Acetate—osteoporosis	0.00396	0.0141	CcSEcCtD
Amlexanox—Paraesthesia—Etidronic acid—osteoporosis	0.00393	0.014	CcSEcCtD
Amlexanox—Liver function test abnormal—Estradiol—osteoporosis	0.00376	0.0134	CcSEcCtD
Amlexanox—Nervous system disorder—Estropipate—osteoporosis	0.00371	0.0132	CcSEcCtD
Amlexanox—Nervous system disorder—Raloxifene—osteoporosis	0.0036	0.0128	CcSEcCtD
Amlexanox—Nervous system disorder—Ibandronate—osteoporosis	0.00356	0.0127	CcSEcCtD
Amlexanox—Nausea—Ergocalciferol—osteoporosis	0.0035	0.0124	CcSEcCtD
Amlexanox—Paraesthesia—Estropipate—osteoporosis	0.0034	0.0121	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Estropipate—osteoporosis	0.00327	0.0116	CcSEcCtD
Amlexanox—Paraesthesia—Ibandronate—osteoporosis	0.00326	0.0116	CcSEcCtD
Amlexanox—Pain—Estropipate—osteoporosis	0.00324	0.0115	CcSEcCtD
Amlexanox—Pain—Alendronate—osteoporosis	0.00319	0.0113	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00317	0.0113	CcSEcCtD
Amlexanox—Pain—Raloxifene—osteoporosis	0.00314	0.0111	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00314	0.0111	CcSEcCtD
Amlexanox—Pain—Ibandronate—osteoporosis	0.00311	0.011	CcSEcCtD
Amlexanox—Pain—Calcitriol—osteoporosis	0.00304	0.0108	CcSEcCtD
Amlexanox—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00301	0.0107	CcSEcCtD
Amlexanox—Nervous system disorder—Risedronate—osteoporosis	0.00294	0.0104	CcSEcCtD
Amlexanox—Nervous system disorder—Pamidronate—osteoporosis	0.00279	0.00992	CcSEcCtD
Amlexanox—Headache—Etidronic acid—osteoporosis	0.00274	0.00975	CcSEcCtD
Amlexanox—Paraesthesia—Risedronate—osteoporosis	0.00269	0.00955	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00265	0.00942	CcSEcCtD
Amlexanox—Nausea—Etidronic acid—osteoporosis	0.0026	0.00924	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Risedronate—osteoporosis	0.00258	0.00918	CcSEcCtD
Amlexanox—Pain—Risedronate—osteoporosis	0.00256	0.0091	CcSEcCtD
Amlexanox—Paraesthesia—Pamidronate—osteoporosis	0.00255	0.00908	CcSEcCtD
Amlexanox—Nervous system disorder—Zoledronate—osteoporosis	0.00255	0.00906	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00246	0.00873	CcSEcCtD
Amlexanox—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00245	0.00872	CcSEcCtD
Amlexanox—Pain—Pamidronate—osteoporosis	0.00243	0.00865	CcSEcCtD
Amlexanox—Headache—Estropipate—osteoporosis	0.00237	0.00843	CcSEcCtD
Amlexanox—Headache—Alendronate—osteoporosis	0.00234	0.0083	CcSEcCtD
Amlexanox—Paraesthesia—Zoledronate—osteoporosis	0.00233	0.00829	CcSEcCtD
Amlexanox—Headache—Raloxifene—osteoporosis	0.0023	0.00817	CcSEcCtD
Amlexanox—Headache—Ibandronate—osteoporosis	0.00228	0.00809	CcSEcCtD
Amlexanox—Nausea—Estropipate—osteoporosis	0.00225	0.00799	CcSEcCtD
Amlexanox—Paraesthesia—Conjugated Estrogens—osteoporosis	0.00225	0.00799	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00224	0.00797	CcSEcCtD
Amlexanox—Headache—Calcitriol—osteoporosis	0.00223	0.00791	CcSEcCtD
Amlexanox—Pain—Zoledronate—osteoporosis	0.00222	0.0079	CcSEcCtD
Amlexanox—Nausea—Alendronate—osteoporosis	0.00222	0.00787	CcSEcCtD
Amlexanox—Nausea—Raloxifene—osteoporosis	0.00218	0.00774	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00216	0.00768	CcSEcCtD
Amlexanox—Nausea—Ibandronate—osteoporosis	0.00216	0.00767	CcSEcCtD
Amlexanox—Pain—Conjugated Estrogens—osteoporosis	0.00214	0.0076	CcSEcCtD
Amlexanox—Nausea—Calcitriol—osteoporosis	0.00211	0.0075	CcSEcCtD
Amlexanox—Nervous system disorder—Estradiol—osteoporosis	0.00196	0.00698	CcSEcCtD
Amlexanox—Headache—Ethinyl Estradiol—osteoporosis	0.00192	0.00683	CcSEcCtD
Amlexanox—Headache—Risedronate—osteoporosis	0.00188	0.00666	CcSEcCtD
Amlexanox—Nausea—Ethinyl Estradiol—osteoporosis	0.00182	0.00648	CcSEcCtD
Amlexanox—Paraesthesia—Estradiol—osteoporosis	0.0018	0.00639	CcSEcCtD
Amlexanox—Headache—Pamidronate—osteoporosis	0.00178	0.00633	CcSEcCtD
Amlexanox—Nausea—Risedronate—osteoporosis	0.00178	0.00632	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Estradiol—osteoporosis	0.00173	0.00614	CcSEcCtD
Amlexanox—PDE4B—bone marrow—osteoporosis	0.00172	0.0397	CbGeAlD
Amlexanox—Pain—Estradiol—osteoporosis	0.00171	0.00609	CcSEcCtD
Amlexanox—Nausea—Pamidronate—osteoporosis	0.00169	0.00601	CcSEcCtD
Amlexanox—Headache—Zoledronate—osteoporosis	0.00163	0.00579	CcSEcCtD
Amlexanox—Headache—Conjugated Estrogens—osteoporosis	0.00157	0.00557	CcSEcCtD
Amlexanox—Nausea—Zoledronate—osteoporosis	0.00154	0.00549	CcSEcCtD
Amlexanox—Nausea—Conjugated Estrogens—osteoporosis	0.00149	0.00528	CcSEcCtD
Amlexanox—Headache—Estradiol—osteoporosis	0.00125	0.00446	CcSEcCtD
Amlexanox—Nausea—Estradiol—osteoporosis	0.00119	0.00423	CcSEcCtD
Amlexanox—PDE4D—Signaling Pathways—TLN1—osteoporosis	0.000277	0.000423	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—KL—osteoporosis	0.000276	0.000421	CbGpPWpGaD
Amlexanox—FGF1—Disease—GAPDH—osteoporosis	0.000275	0.000419	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—P4HB—osteoporosis	0.000274	0.000419	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—CALCA—osteoporosis	0.000273	0.000417	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	0.000271	0.000413	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—TGFB1—osteoporosis	0.00027	0.000413	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	0.00027	0.000412	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—LRP6—osteoporosis	0.000269	0.000411	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—POMC—osteoporosis	0.000269	0.000411	CbGpPWpGaD
Amlexanox—S100A12—Immune System—AGER—osteoporosis	0.000269	0.00041	CbGpPWpGaD
Amlexanox—S100A12—Immune System—ADCY5—osteoporosis	0.000268	0.000409	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PTH—osteoporosis	0.000267	0.000407	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—AGER—osteoporosis	0.000264	0.000403	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TLN1—osteoporosis	0.000264	0.000402	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—ADCY5—osteoporosis	0.000263	0.000401	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—IL6R—osteoporosis	0.000262	0.000401	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—RAP1A—osteoporosis	0.000262	0.0004	CbGpPWpGaD
Amlexanox—FGF1—Disease—NFATC1—osteoporosis	0.000261	0.000399	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CNR2—osteoporosis	0.00026	0.000397	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—IL6—osteoporosis	0.000259	0.000396	CbGpPWpGaD
Amlexanox—FGF1—Disease—DKK1—osteoporosis	0.000259	0.000395	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—ADCY5—osteoporosis	0.000258	0.000394	CbGpPWpGaD
Amlexanox—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—osteoporosis	0.000258	0.000394	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—NFATC1—osteoporosis	0.000256	0.00039	CbGpPWpGaD
Amlexanox—IL3—Immune System—IRS1—osteoporosis	0.000255	0.00039	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—DKK1—osteoporosis	0.000254	0.000387	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—CALCA—osteoporosis	0.000253	0.000386	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	0.000252	0.000385	CbGpPWpGaD
Amlexanox—FGF1—Disease—WNT1—osteoporosis	0.00025	0.000381	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling of activated FGFR—IL6—osteoporosis	0.000248	0.000379	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—WNT1—osteoporosis	0.000244	0.000373	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—IL6—osteoporosis	0.000244	0.000373	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TLN1—osteoporosis	0.000244	0.000372	CbGpPWpGaD
Amlexanox—FGF1—Disease—FGA—osteoporosis	0.000243	0.000371	CbGpPWpGaD
Amlexanox—IL3—Immune System—IL6R—osteoporosis	0.00024	0.000366	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—P4HB—osteoporosis	0.000239	0.000364	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—FGA—osteoporosis	0.000238	0.000363	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—ADCY5—osteoporosis	0.000234	0.000358	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IRS2—osteoporosis	0.000234	0.000358	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—IL6—osteoporosis	0.000233	0.000356	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PTH—osteoporosis	0.000232	0.000354	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—IL6—osteoporosis	0.000232	0.000354	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—IL6—osteoporosis	0.000231	0.000352	CbGpPWpGaD
Amlexanox—FGF1—Immune System—PSMA2—osteoporosis	0.000231	0.000352	CbGpPWpGaD
Amlexanox—FGF1—Immune System—PSMA5—osteoporosis	0.000231	0.000352	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—IRS2—osteoporosis	0.00023	0.000351	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—IL6—osteoporosis	0.00023	0.000351	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—RAP1A—osteoporosis	0.000228	0.000348	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TLN1—osteoporosis	0.000227	0.000347	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—P4HB—osteoporosis	0.000227	0.000347	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CNR2—osteoporosis	0.000226	0.000345	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—ADCY5—osteoporosis	0.000225	0.000343	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—NFATC1—osteoporosis	0.000223	0.00034	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PTHLH—osteoporosis	0.000221	0.000337	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—BMP2—osteoporosis	0.000221	0.000337	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PTH—osteoporosis	0.000221	0.000337	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—DKK1—osteoporosis	0.000221	0.000337	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—IRS2—osteoporosis	0.000221	0.000337	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—RAP1A—osteoporosis	0.000217	0.000332	CbGpPWpGaD
Amlexanox—FGF1—Disease—ENO1—osteoporosis	0.000216	0.00033	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—FGB—osteoporosis	0.000216	0.00033	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—IL6—osteoporosis	0.000216	0.00033	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—IL6—osteoporosis	0.000216	0.00033	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—IL6—osteoporosis	0.000216	0.00033	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—ADCY5—osteoporosis	0.000216	0.00033	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CNR2—osteoporosis	0.000215	0.000329	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—IL6—osteoporosis	0.000214	0.000327	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—ADCY5—osteoporosis	0.000214	0.000326	CbGpPWpGaD
Amlexanox—FGF1—Disease—PSMA2—osteoporosis	0.000213	0.000325	CbGpPWpGaD
Amlexanox—FGF1—Disease—PSMA5—osteoporosis	0.000213	0.000325	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—WNT1—osteoporosis	0.000213	0.000325	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—IL6—osteoporosis	0.000212	0.000324	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NFATC1—osteoporosis	0.000212	0.000323	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—IL6—osteoporosis	0.000211	0.000323	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—P4HB—osteoporosis	0.00021	0.000321	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—DKK1—osteoporosis	0.00021	0.000321	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—SPP1—osteoporosis	0.000209	0.000319	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PSMA2—osteoporosis	0.000209	0.000319	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PSMA5—osteoporosis	0.000209	0.000319	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—FGA—osteoporosis	0.000207	0.000316	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IRS1—osteoporosis	0.000205	0.000312	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PTH—osteoporosis	0.000205	0.000312	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—ADCY5—osteoporosis	0.000204	0.000311	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—WNT1—osteoporosis	0.000203	0.000309	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—RAP1A—osteoporosis	0.000201	0.000307	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—IRS1—osteoporosis	0.000201	0.000306	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CNR2—osteoporosis	0.000199	0.000304	CbGpPWpGaD
Amlexanox—FGF1—Disease—CALCA—osteoporosis	0.000199	0.000303	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—ADCY5—osteoporosis	0.000198	0.000302	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—FGA—osteoporosis	0.000197	0.000301	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NFATC1—osteoporosis	0.000196	0.000299	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—P4HB—osteoporosis	0.000196	0.000299	CbGpPWpGaD
Amlexanox—FGF1—Immune System—KL—osteoporosis	0.000195	0.000298	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CALCA—osteoporosis	0.000195	0.000297	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—DKK1—osteoporosis	0.000195	0.000297	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—ADCY5—osteoporosis	0.000194	0.000296	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—IRS1—osteoporosis	0.000193	0.000294	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PTHLH—osteoporosis	0.000192	0.000294	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—BMP2—osteoporosis	0.000192	0.000294	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL6R—osteoporosis	0.000192	0.000293	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—IL6—osteoporosis	0.000192	0.000292	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PTH—osteoporosis	0.000191	0.000291	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—POMC—osteoporosis	0.00019	0.00029	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IRS2—osteoporosis	0.000189	0.000289	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—IL6R—osteoporosis	0.000189	0.000288	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—FGB—osteoporosis	0.000188	0.000287	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—RAP1A—osteoporosis	0.000187	0.000286	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—WNT1—osteoporosis	0.000187	0.000286	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CNR2—osteoporosis	0.000186	0.000284	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—LEP—osteoporosis	0.000185	0.000282	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PTHLH—osteoporosis	0.000183	0.00028	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—BMP2—osteoporosis	0.000183	0.00028	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NFATC1—osteoporosis	0.000183	0.000279	CbGpPWpGaD
Amlexanox—IL3—Immune System—IL1B—osteoporosis	0.000182	0.000278	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—FGA—osteoporosis	0.000182	0.000278	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PSMA2—osteoporosis	0.000182	0.000278	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PSMA5—osteoporosis	0.000182	0.000278	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—DKK1—osteoporosis	0.000181	0.000277	CbGpPWpGaD
Amlexanox—FGF1—Disease—KL—osteoporosis	0.00018	0.000275	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—ADCY5—osteoporosis	0.00018	0.000274	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—FGB—osteoporosis	0.000179	0.000274	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—KL—osteoporosis	0.000177	0.00027	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—ESR1—osteoporosis	0.000177	0.00027	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—WNT1—osteoporosis	0.000175	0.000267	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PSMA2—osteoporosis	0.000173	0.000264	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PSMA5—osteoporosis	0.000173	0.000264	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—POMC—osteoporosis	0.000172	0.000263	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—FGA—osteoporosis	0.00017	0.000259	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PTHLH—osteoporosis	0.00017	0.000259	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—BMP2—osteoporosis	0.00017	0.000259	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CALCA—osteoporosis	0.000169	0.000259	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—IL6R—osteoporosis	0.000168	0.000257	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—FGB—osteoporosis	0.000166	0.000253	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—POMC—osteoporosis	0.000165	0.000252	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IRS1—osteoporosis	0.000165	0.000252	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CALCA—osteoporosis	0.000161	0.000246	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PSMA2—osteoporosis	0.00016	0.000244	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PSMA5—osteoporosis	0.00016	0.000244	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—POMC—osteoporosis	0.000159	0.000243	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PTHLH—osteoporosis	0.000158	0.000241	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—BMP2—osteoporosis	0.000158	0.000241	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—POMC—osteoporosis	0.000157	0.00024	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IL6R—osteoporosis	0.000155	0.000237	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—FGB—osteoporosis	0.000155	0.000236	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—KL—osteoporosis	0.000154	0.000235	CbGpPWpGaD
Amlexanox—FGF1—Immune System—AGER—osteoporosis	0.000154	0.000234	CbGpPWpGaD
Amlexanox—FGF1—Immune System—ADCY5—osteoporosis	0.000153	0.000234	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IGF1—osteoporosis	0.000153	0.000233	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—POMC—osteoporosis	0.00015	0.000229	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PSMA2—osteoporosis	0.000149	0.000228	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PSMA5—osteoporosis	0.000149	0.000228	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CALCA—osteoporosis	0.000149	0.000228	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—IL6—osteoporosis	0.000147	0.000225	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—IL6—osteoporosis	0.000147	0.000224	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—KL—osteoporosis	0.000146	0.000224	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—IL6R—osteoporosis	0.000146	0.000223	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL1B—osteoporosis	0.000146	0.000223	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—POMC—osteoporosis	0.000146	0.000222	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—POMC—osteoporosis	0.000143	0.000218	CbGpPWpGaD
Amlexanox—FGF1—Disease—ADCY5—osteoporosis	0.000141	0.000216	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—IL6R—osteoporosis	0.000139	0.000213	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CALCA—osteoporosis	0.000139	0.000212	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—ADCY5—osteoporosis	0.000138	0.000211	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—KL—osteoporosis	0.000136	0.000207	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—SPP1—osteoporosis	0.000134	0.000204	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IRS2—osteoporosis	0.000134	0.000204	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—POMC—osteoporosis	0.000132	0.000202	CbGpPWpGaD
Amlexanox—FGF1—Disease—MTHFR—osteoporosis	0.00013	0.000198	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—IL6R—osteoporosis	0.000129	0.000197	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—KL—osteoporosis	0.000126	0.000193	CbGpPWpGaD
Amlexanox—FGF1—Disease—IRS2—osteoporosis	0.000124	0.000189	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IRS2—osteoporosis	0.000121	0.000185	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—ADCY5—osteoporosis	0.000121	0.000184	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—LEP—osteoporosis	0.000119	0.000181	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IRS1—osteoporosis	0.000117	0.000178	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—IL6—osteoporosis	0.000117	0.000178	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—SPP1—osteoporosis	0.000117	0.000178	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—ADCY5—osteoporosis	0.000115	0.000175	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—ESR1—osteoporosis	0.000113	0.000173	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—SPP1—osteoporosis	0.000111	0.000169	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL6R—osteoporosis	0.00011	0.000168	CbGpPWpGaD
Amlexanox—FGF1—Disease—IRS1—osteoporosis	0.000108	0.000165	CbGpPWpGaD
Amlexanox—IL3—Immune System—IL6—osteoporosis	0.000107	0.000163	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—ADCY5—osteoporosis	0.000106	0.000162	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IRS1—osteoporosis	0.000106	0.000161	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IRS2—osteoporosis	0.000105	0.000161	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—LEP—osteoporosis	0.000103	0.000158	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—SPP1—osteoporosis	0.000103	0.000157	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—POMC—osteoporosis	0.000102	0.000155	CbGpPWpGaD
Amlexanox—FGF1—Disease—IL6R—osteoporosis	0.000101	0.000155	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IRS2—osteoporosis	0.0001	0.000153	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL6R—osteoporosis	9.93e-05	0.000152	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—ADCY5—osteoporosis	9.9e-05	0.000151	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—ESR1—osteoporosis	9.85e-05	0.00015	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—LEP—osteoporosis	9.82e-05	0.00015	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IGF1—osteoporosis	9.8e-05	0.00015	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SPP1—osteoporosis	9.58e-05	0.000146	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—ESR1—osteoporosis	9.38e-05	0.000143	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IRS2—osteoporosis	9.29e-05	0.000142	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IRS1—osteoporosis	9.21e-05	0.000141	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MYC—osteoporosis	9.19e-05	0.00014	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TGFB1—osteoporosis	9.17e-05	0.00014	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—LEP—osteoporosis	9.09e-05	0.000139	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—POMC—osteoporosis	8.87e-05	0.000135	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IRS1—osteoporosis	8.76e-05	0.000134	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—ESR1—osteoporosis	8.68e-05	0.000132	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IRS2—osteoporosis	8.66e-05	0.000132	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL6R—osteoporosis	8.65e-05	0.000132	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL6—osteoporosis	8.56e-05	0.000131	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IGF1—osteoporosis	8.53e-05	0.00013	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—LEP—osteoporosis	8.47e-05	0.000129	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—POMC—osteoporosis	8.44e-05	0.000129	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—IL6—osteoporosis	8.4e-05	0.000128	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL1B—osteoporosis	8.36e-05	0.000128	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL6R—osteoporosis	8.23e-05	0.000126	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IGF1—osteoporosis	8.12e-05	0.000124	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IRS1—osteoporosis	8.11e-05	0.000124	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—ESR1—osteoporosis	8.09e-05	0.000123	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—POMC—osteoporosis	7.81e-05	0.000119	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL6R—osteoporosis	7.62e-05	0.000116	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IRS1—osteoporosis	7.56e-05	0.000115	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IGF1—osteoporosis	7.51e-05	0.000115	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—IL6—osteoporosis	7.49e-05	0.000114	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—POMC—osteoporosis	7.28e-05	0.000111	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL6R—osteoporosis	7.1e-05	0.000108	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IGF1—osteoporosis	7e-05	0.000107	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IL6—osteoporosis	6.91e-05	0.000105	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—IL6—osteoporosis	6.52e-05	9.95e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—IL6—osteoporosis	6.21e-05	9.47e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—MYC—osteoporosis	6.01e-05	9.17e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—TGFB1—osteoporosis	6e-05	9.15e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MYC—osteoporosis	5.89e-05	8.98e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TGFB1—osteoporosis	5.87e-05	8.96e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—IL6—osteoporosis	5.74e-05	8.77e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MYC—osteoporosis	5.12e-05	7.82e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TGFB1—osteoporosis	5.11e-05	7.8e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL6—osteoporosis	4.89e-05	7.47e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MYC—osteoporosis	4.88e-05	7.44e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TGFB1—osteoporosis	4.87e-05	7.43e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—IL6—osteoporosis	4.52e-05	6.89e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MYC—osteoporosis	4.51e-05	6.89e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TGFB1—osteoporosis	4.5e-05	6.87e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL6—osteoporosis	4.43e-05	6.75e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MYC—osteoporosis	4.21e-05	6.42e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TGFB1—osteoporosis	4.2e-05	6.41e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL6—osteoporosis	3.85e-05	5.88e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL6—osteoporosis	3.67e-05	5.6e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL6—osteoporosis	3.39e-05	5.18e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL6—osteoporosis	3.16e-05	4.83e-05	CbGpPWpGaD
